PLX

MKT CAP:$170M

Protalix Biotherapeutics Inc

Market Cap

$170M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$1.99+$0.25 (+14.37%)

Jun 5, 2026

52W High $3.1552W Low $1.35

Company Details

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company pr...

CEO

—

IPO Date

May 15, 1998

Website

www.protalix.com

Key Metrics TTM

Revenue

$76M

+27.8% YoY

Net Income

$15M

EPS (Diluted)

Free Cash Flow

$15M

Revenue / Share

$0.92

Gross Margin

70.0%

Operating Margin

25.9%

Net Margin

20.1%

FCF Margin

19.2%

P/S

2.2x

P/E

11.1x

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 13, 2026

$34M+233.7%

FY 2025

Mar 18, 2026

$53M-1.2%

Q4 2025

Mar 18, 2026

$9M-49.9%

Q3 2025

Nov 13, 2025

$18M-0.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee